From the Journals

TAVI Reduces GI Lesions, Bleeding in Heyde

Six months post-TAVI, GI lesion counts in Heyde syndrome patients fell by 68% — with 55% of typical angiodysplasias disappearing, offering a promising dual benefit for aortic stenosis and GI bleeding management.

Share

A recent cohort study evaluated the impact of transcatheter aortic valve implantation (TAVI) on gastrointestinal (GI) angiodysplasia in patients with Heyde syndrome, coexisting aortic stenosis (AS) and GI bleeding. The study revealed a significant reduction in the mean number of vascular lesions per patient post-TAVI, from 6.4 to 2.0. Furthermore, angiogenesis markers decreased significantly after TAVI, suggesting a potential mechanism underlying the reduction in lesion count. TAVI may offer benefits beyond AS management, potentially reducing GI bleeding risk associated with angiodysplasia in Heyde syndrome.

Original Source(s)

TAVI Reduces GI Lesions, Bleeding in Heyde

Six months post-TAVI, GI lesion counts in Heyde syndrome patients fell by 68% — with 55% of typical angiodysplasias disappearing, offering a promising dual benefit for aortic stenosis and GI bleeding management.

  • by Kathryn Wighton

  • November 5, 2024

  • 2 min

Related Content

Ethosuximide vs Placebo for IBS Pain

Randomized trial found no improvement in abdominal pain and higher discontinuation rates with the calcium channel blocker.

Advanced Crohn’s Therapies Show Similar Safety

Large claims analysis finds no significant differences in serious infections, blood clots, or major cardiovascular events across biologics and a Janus kinase inhibitor.

Proton Pump Inhibitors and Cancer Risk

Investigators evaluate cancer risk tied to extended acid suppression therapy.